NDC 68084-214 – Benzonatate
Benzonatate 100 mg/1 · Capsule · Oral
Product NDC68084-214
Product details
- Brand name
- Benzonatate
- Generic name
- Benzonatate
- Labeler
- American Health Packaging
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA040597
- Marketed since
- May 26, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Non-narcotic Antitussive
Active ingredients
- Benzonatate 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68084-214-01 | 10 BLISTER PACK in 1 CARTON (68084-214-01) / 10 CAPSULE in 1 BLISTER PACK (68084-214-11) | May 26, 2021 |
Recalls mentioning this NDC
- D-0257-2024 Jan 31, 2024 · Class III
Superpotent drug: Assay results were slightly above specification at the time zero point. - D-0430-2015 Apr 8, 2015 · Class II
Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Other Benzonatate products
- 50090-6080 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6294 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6850 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6387 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4968 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4969 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5409 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5986 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 87519-111 Benzonatate 150 mg/1 · Capsule · Anvi Pharmaceuticals Inc
- 71610-692 Benzonatate 100 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-573 Benzonatate 100 mg/1 · Capsule · Ascend Laboratories, LLC
- 67877-575 Benzonatate 200 mg/1 · Capsule · Ascend Laboratories, LLC